"THINK Trial: Treatment of Headache With IntraNasal Ketamine: A Randomized Controlled Trial Evaluating the Efficacy of Intranasal Ketamine Versus Standard Therapy in the Management of Primary Headache Syndromes in the Emergency Department"

• Status: Completed
• Trial end date: 2017-10-01

Summary

This is a randomized, single-blind, placebo controlled trial to evaluate the efficacy of sub-dissociative dose ketamine versus standard care therapy for acute headache management of in patients presenting to the emergency department with headache as the chief compliant.

• Phase: Phase 3

Details

• Lead Sponsor: Brooke Army Medical Center
• Treatments: BB 1101; Dexamethasone; Dexamethasone acetate; Diphenhydramine; Ketamine; Ketorolac; Metoclopramide; Promethazine